Bar graph showing proportion of NADCs. by Raymond Atwine (18574812)

“…The Commonest ADC was Kaposi Sarcoma (KS) while the commonest NADC was Squamous cell carcinoma, Not otherwise specified. Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”

Baseline characteristics of study participants. by Raymond Atwine (18574812)

“…The Commonest ADC was Kaposi Sarcoma (KS) while the commonest NADC was Squamous cell carcinoma, Not otherwise specified. Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”

Development and characterization of MPL36 mutants. by Weinan Zhu (1640407)

S1 Data - by Shane R. McClafferty (19434460)

“…Once pups had reached adolescence (PND 50), researchers tested for differences in anxiety, activity, and social behavior using elevated plus-maze, open field habituation, a three-chamber social interaction, and a social discrimination task. …”

Stability of antioxidant vitamins in commercial vitamin supplements by Lucile Tiemi Abe-Matsumoto (6572291)

“…After this period, only one sample showed no significant decrease in vitamin A and E concentrations in relation to the concentrations measured at the beginning of the study. …”

Location of St. Catherines Island. by Nicole R. Cannarozzi (7901057)

Fig 2 - by Sunny Kwok (13124155)

Social discrimination task. by Shane R. McClafferty (19434460)

Similar domain organization of crystallized collagen-binding MSCRAMM adhesins. by Ali Madani (4217290)

Inducing an <i>in silico</i> open-state CNA and demonstrating the natural frequencies of the CNA N1-N2 domains. by Ali Madani (4217290)

S4 Fig - by Jian Zhong (329110)

“…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”

S6 Fig - by Jian Zhong (329110)

“…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”

S3 Fig - by Jian Zhong (329110)

“…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”

S9 Fig - by Jian Zhong (329110)

“…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”

S7 Fig - by Jian Zhong (329110)

“…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”

S1 Raw data - by Jian Zhong (329110)

“…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”

S8 Fig - by Jian Zhong (329110)

“…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”

S2 Fig - by Jian Zhong (329110)

“…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”

S1 Fig - by Jian Zhong (329110)

“…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”

S5 Fig - by Jian Zhong (329110)

“…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”